Skip to content
healthcare.dev

ZEGERID

NDC 68012-054, omeprazole and sodium bicarbonate, powder, for suspension, from Santarus, Inc...

Product NDC
68012-054
Status
Listed
Labeler
Santarus, Inc..
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021636
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68012-054 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMEPRAZOLE40 mg/1
  • SODIUM BICARBONATE1680 mg/1

Pharmacologic classes

Alkalinizing Activity [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
68012-054-03680120054033 PACKET in 1 CARTON (68012-054-03) / 1 POWDER, FOR SUSPENSION in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cd6868b9-5824-442b-8d65-4db29ecb70a4

Use it

Look up 68012-054 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68012-054 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68012-054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.